The inhibition of neutrophil granule enzyme secretion and chemotaxis by pertussis toxin

Pertussis toxin treatment of rabbit peritoneal neutrophils causes a concentration-dependent inhibition of granule enzyme secretion induced by formylmethionyl-leucyl-phenylalanine, C5a, and leukotriene B4. It also inhibits chemotaxis induced by formylmethionyl-leucyl- phenylalanine. The same toxin treatment, however, has no effect on granule enzyme secretion induced by the calcium ionophore A23187 or phorbol 12-myristate 13-acetate. Moreover, pertussis toxin treatment does not affect either the number or affinity of the formylpeptide receptors on the neutrophil nor does it have any effect on the unstimulated levels of cyclic AMP (cAMP) or the transient rise in cAMP induced by chemotactic factor stimulation in these cells. We hypothesize that pertussis toxin, as in other cells, interacts with a GTP binding regulatory protein identical with or analogous to either Ni or transducin which mediates the receptor-induced inhibition or activation of a target protein or proteins required in neutrophil activation. The nature of the target protein is unknown, but it is not the catalytic unit of adenylate cyclase. The target protein acts after binding of chemotactic factor to its receptor in the sequence that leads to the receptor-induced rise in intracellular Ca2+. It does not affect the responses elicited by the direct introduction of calcium into the cells or the activity of protein kinase C.

[1]  A. Gilman,et al.  Inhibition of receptor-mediated release of arachidonic acid by pertussis toxin , 1984, Cell.

[2]  M. Ui,et al.  ADP-ribosylation of the specific membrane protein by islet-activating protein, pertussis toxin, associated with inhibition of a chemotactic peptide-induced arachidonate release in neutrophils. A possible role of the toxin substrate in Ca2+-mobilizing biosignaling. , 1984, The Journal of biological chemistry.

[3]  T. Molski,et al.  Pertussis toxin inhibits the rise in the intracellular concentration of free calcium that is induced by chemotactic factors in rabbit neutrophils: possible role of the "G proteins" in calcium mobilization. , 1984, Biochemical and biophysical research communications.

[4]  R. Snyderman.  Regulatory mechanisms of a chemoattractant receptor on leukocytes. , 1984, Federation proceedings.

[5]  M. Ui,et al.  Islet‐activating protein, pertussis toxin, inhibits Ca2+‐induced and guanine nucleotide‐dependent releases of histamine and arachidonic acid from rat mast cells , 1984, FEBS letters.

[6]  K. Austen,et al.  Localization of histaminase to the specific granule of the human neutrophil. , 1984, Immunology.

[7]  H. Dohlman,et al.  Effect of pertussis toxin on α2‐adrenoceptors: decreased formation of the high‐affinity state for agonists , 1984, FEBS letters.

[8]  M. Klempner,et al.  The beta-adrenergic receptor in the human neutrophil plasma membrane: receptor-cyclase uncoupling is associated with amplified GTP activation. , 1984, Journal of immunology.

[9]  M. Houslay.  A family of guanine nucleotide regulatory proteins , 1984 .

[10]  A. Jesaitis,et al.  Evidence for N‐formyl chemotactic peptide‐stimulated GTPase activity in human neutrophil homogenates , 1984, FEBS letters.

[11]  M. Ui.  Islet-activating protein, pertussis toxin: a probe for functions of the inhibitory guanine nucleotide regulatory component of adenylate cyclase , 1984 .

[12]  M. Ui,et al.  Suppression of passive cutaneous anaphylaxis by pertussis toxin, an islet-activating protein, as a result of inhibition of histamine release from mast cells. , 1983, Biochemical pharmacology.

[13]  T. Kuno,et al.  Selective decrease in the affinity of D2 dopamine receptor for agonist induced by islet-activating protein, pertussis toxin, associated with ADP-ribosylation of the specific membrane protein of bovine striatum. , 1983, Biochemical and biophysical research communications.

[14]  B. Bormann,et al.  A simple and rapid assay for measuring radiolabeled ligand binding to purified plasma membranes. , 1983, Analytical biochemistry.

[15]  M. Vadas,et al.  Enhancement of the intensity, persistence, and passive transfer of delayed-type hypersensitivity lesions by pertussigen in mice , 1983, The Journal of experimental medicine.

[16]  T. Katada,et al.  Specific uncoupling by islet-activating protein, pertussis toxin, of negative signal transduction via alpha-adrenergic, cholinergic, and opiate receptors in neuroblastoma x glioma hybrid cells. , 1983, The Journal of biological chemistry.

[17]  J. Atkinson,et al.  Evidence that the functional responses of human neutrophils occur independently of transient elevations in cyclic AMP levels. , 1983, Journal of cyclic nucleotide and protein phosphorylation research.

[18]  C. Huang,et al.  The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities. , 1982, Journal of immunology.

[19]  R. Lefkowitz,et al.  The oligopeptide chemotactic factor receptor on human polymorphonuclear leukocyte membranes exists in two affinity states. , 1982, Biochemical and biophysical research communications.

[20]  T. Katada,et al.  Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Munoz,et al.  Crystallization of pertussigen from Bordetella pertussis , 1981, Infection and immunity.

[22]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[23]  J. Wissler,et al.  A transient rise in cyclic AMP levels following chemotactic stimulation of neutrophil granulocytes. , 1979, Cell biology international reports.

[24]  R. Sha’afi,et al.  Response of adenosine cyclic 3',5'-monophosphate level in rabbit neutrophils to the chemotactic peptide formyl-methionyl-leucyl-phenylalanine. , 1979, Molecular pharmacology.

[25]  P. Ward,et al.  Biochemical quantitation of the chemotactic factor inactivator activity in human serum. , 1979, The Journal of laboratory and clinical medicine.

[26]  J. Moss,et al.  Activation of adenylate cyclase by choleragen. , 1979, Annual review of biochemistry.

[27]  P. Naccache,et al.  The effects of extracellular K+, Na+ and Ca++ on lysosomal enzyme secretion from polymorphonuclear leukocytes. , 1977, Journal of immunology.

[28]  M. Swanson.  A simple multiple chamber apparatus for measuring chemotaxis of polymorphonuclear leukocytes utilizing centrifugation of the chambers before incubation. , 1977, Journal of immunological methods.

[29]  S. Zigmond,et al.  The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils , 1976, The Journal of experimental medicine.

[30]  J. Rosenblatt,et al.  The role of cyclic AMP in the chemotactic responsiveness and spontaneous motility of rabbit peritoneal neutrophils. The inhibition of neutrophil movement and the elevation of cyclic AMP levels by catecholamines, prostaglandins, theophylline and cholera toxin. , 1975, Journal of immunology.

[31]  H. Hill,et al.  Modulation of human neutrophil chemotactic responses by cyclic 3',5'-guanosine monophosphate and cyclic 3',5'-adenosine monophosphate. , 1975, Metabolism: clinical and experimental.